UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)
ACCREDO HEALTH, INC./1/
-----------------------------------
(Name of Issuer)
Common Stock
-----------------------------------
(Title of Class of Securities)
00437V104
----------------------
(CUSIP Number)
November 19, 1999
--------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|X| Rule 13d-1(b)
o Rule 13d-1(c)
o Rule 13d-1(d)
- ------------------------
/1/ The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that Section of the Act but shall be subject to all other provisions of the
Act (however, see the Notes).
<PAGE>
Schedule 13G Page 2 of 13
CUSIP No. 00437V104 Accredo Health, Inc.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Berger LLC/2/ ID No. 84-1507541
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Nevada
- --------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES -0-
------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 460,870
------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING -0-
------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH 460,870
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
460,870
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES |_|
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.03%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
IA, CO
- --------------------------------------------------------------------------------
- ------------------------
/2/ Berger LLC was formerly known as Berger Associates, Inc.
<PAGE>
Schedule 13G Page 3 of 13
CUSIP No. 00437V104 Accredo Health, Inc.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Kansas City Southern Industries, Inc. ID No. 44-0663509
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES -0-
------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY -0-
------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING -0-
------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH -0-
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
-0-
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES |X|
Excludes shares beneficially owned by Berger LLC as to which
beneficial ownership is disclaimed.
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
-0-
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
HC, CO
- --------------------------------------------------------------------------------
<PAGE>
Schedule 13G Page 4 of 13
CUSIP No. 00437V104 Accredo Health, Inc.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Stilwell Financial, Inc. ID No. 43-1804048
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES -0-
------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY -0-
------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING -0-
------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH -0-
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
-0-
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES |X|
Excludes shares beneficially owned by Berger LLC as to which
beneficial ownership is disclaimed.
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
-0-
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
HC, CO
- --------------------------------------------------------------------------------
<PAGE>
Schedule 13G Page 5 of 13
CUSIP No. 00437V104 Accredo Health, Inc.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Stilwell Management, Inc. ID No. 13-2750052
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES -0-
------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY -0-
------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING -0-
------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH -0-
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
-0-
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES |X|
Excludes shares beneficially owned by Berger LLC as to which
beneficial ownership is disclaimed.
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
-0-
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON**
CO
- --------------------------------------------------------------------------------
**This section was amended to remove the code HC, which was previously
included in error.
<PAGE>
Schedule 13G Page 6 of 13
CUSIP No. 00437V104 Accredo Health, Inc.
- --------------------------------------------------------------------------------
Item 1.
(a) Name of Issuer: Accredo Health, Inc.
(b) Address of Issuer's Principal Executive Offices:
1640 Century Center Parkway, Suite 101
Memphis, TN 38134
Item 2.
(a) Name of Person Filing:
(1) Berger LLC
(2) Kansas City Southern Industries, Inc.
(3) Stilwell Financial, Inc.
(4) Stilwell Management, Inc.
(b) Address of Principal Business Office:
(1) Berger LLC
210 University Boulevard, Suite 900
Denver, Colorado 80206
(2) Kansas City Southern Industries, Inc.
114 West 11th Street
Kansas City, Missouri 64105
(3) Stilwell Financial, Inc.
114 West 11th Street
Kansas City, Missouri 64105
(4) Stilwell Management, Inc.
210 University Boulevard, Suite 900
Denver, Colorado 80206
(c) Citizenship:
(1) Berger LLC: Nevada
(2) Kansas City Southern Industries, Inc.: Delaware
(3) Stilwell Financial, Inc. Delaware
<PAGE>
Schedule 13G Page 7 of 13
CUSIP No. 00437V104 Accredo Health, Inc.
- --------------------------------------------------------------------------------
(4) Stilwell Management, Inc. Delaware
(d) Title of Class of Securities: Common Stock
(e) CUSIP Number: 00437V104
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or
13d-2(b), check whether the person filing is a:
(a) ________ Broker or Dealer registered under Section 15 of the
Act
(b) ________ Bank as defined in section 3(a)(6) of the Act
(c) ________ Insurance Company as defined in section 3(a)(19) of
the Act
(d) ________ Investment Company registered under section 8 of the
Investment Company Act.
(e) X Investment Adviser registered under section 203 of
-------- the Investment Advisers Act of 1940 /3/
(f) ________ Employee Benefit Plan, Pension Fund which is subject
to the provisions of the Employee Retirement Income
Security Act of 1974 or Endowment Fund; see section
240.13d-1(b)(1)(ii)(F)
(g) X Parent Holding Company or Control Person, in
-------- accordance with section 240.13d-1(b)(1)(ii)(G)
(Note: See Item 7) /4/
(h) ________ Group, in accordance with
section 240.13d-1(b)(1)(ii)(H)
- ------------------------
/3/ Berger LLC is a registered investment adviser.
/4/ Kansas City Southern Industries ("KSCI") is the parent holding company of
Stilwell Financial, Inc. ("SFI"). SFI owns 100% of Stilwell Management,
Inc. ("SMI"), which owns approximately 86% of Berger LLC. Each of these
entities is filing this statement solely as a result of such stock
ownership which may be deemed to give KCSI, SFI or SMI control over Berger
LLC.
<PAGE>
Schedule 13G Page 8 of 13
CUSIP No. 00437V104 Accredo Health, Inc.
- --------------------------------------------------------------------------------
Item 4. Ownership
(a) Amount Beneficially Owned:
(1) Berger LLC: 460,870 /5/
----------
(2) Kansas City Southern Industries, Inc.: 0 /6/
--------
(3) Stilwell Financial, Inc.: 0 /7/
-------------
(4) Stilwell Management, Inc.: 0 /8/
-------------
- ------------------------
/5/ The filing of this statement shall not be construed as an admission that
Berger LLC is, for purposes of Sections 13(d) or 13(g) of the Securities
Exchange Act of 1934, the beneficial owner of any securities covered by
this statement.
Berger LLC is a registered investment adviser which furnishes investment
advice to a number of mutual funds and institutional clients. As a result
of its role as investment adviser or sub-adviser to the Funds as well as
institutional clients, Berger LLC may be deemed to be the beneficial owner
of securities held by such funds or clients.
/6/ Kansas City Southern Industries, Inc. ("KCSI") does not own of record any
shares of Accredo Health, Inc. Common Stock, it has not engaged in
any transaction in Accredo Health, Inc. Common Stock, and it does
not exercise any voting or investment power over shares of Universal
Electronics, Inc. Common Stock. All shares reported herein have been
acquired by Berger LLC's mutual fund clients and KCSI specifically
disclaims beneficial ownership over any shares of Accredo Health,
Inc. Common Stock.
Accordingly, the filing of this statement shall not be construed as an
admission that KCSI is, for purposes of Sections 13(d) or 13(g) of the
Securities Exchange Act of 1934, the beneficial owner of any securities
covered by this statement.
/7/ Stilwell Financial, Inc. ("SFI") does not own of record any shares of
Accredo Health, Inc. Common Stock, it has not engaged in any
transaction in Accredo Health, Inc. Common Stock, and it does not
exercise any voting or investment power over shares of Universal
Electronics, Inc. Common Stock. All shares reported herein have been
acquired by Berger LLC's mutual fund clients and SFI specifically disclaims
beneficial ownership over any shares of Accredo Health, Inc. Common
Stock.
Accordingly, the filing of this statement shall not be construed as an
admission that SFI is, for purposes of Sections 13(d) or 13(g) of the
Securities Exchange Act of 1934, the beneficial owner of any securities
covered by this statement.
/8/ Stilwell Management, Inc. ("SMI") does not own of record any shares of
Accredo Health, Inc. Common Stock, it has not engaged in any
transaction in Accredo Health, Inc. Common Stock, and it does not
exercise any voting or investment power over shares of Universal
Electronics, Inc. Common Stock. All shares reported herein have been
acquired by Berger LLC's mutual fund clients and SMI specifically disclaims
beneficial
<PAGE>
Schedule 13G Page 9 of 13
CUSIP No. 00437V104 Accredo Health, Inc.
- --------------------------------------------------------------------------------
(b) Percent of Class:
(1) Berger LLC: 5.03%
----------
(2) Kansas City Southern Industries, Inc. 0.0% /9/
---------
(3) Stilwell Financial, Inc.: 0.0% /10/
------
(4) Stilwell Management, Inc.: 0.0% /11/
------
(c) Number of shares as to which such person has:
(1) Berger LLC:
(i) Sole power to vote or to direct the
vote: 0
--------
(ii) Shared power to vote or to direct the
vote: 460,870
----------
(iii) Sole power to dispose or to direct the
disposition of: 0
--------
(iv) Shared power to dispose or to direct the
disposition of: 460,870
-----------
(2) Kansas City Southern Industries, Inc.
(i) Sole power to vote or to direct the
vote: 0
-----
(ii) Shared power to vote or to direct the
vote: 0 /12/
-----
(iii) Sole power to dispose or to direct the
disposition of: 0
-----
- ------------------------
ownership over any shares of Accredo Health, Inc. Common Stock.
Accordingly, the filing of this statement shall not be construed as an
admission that SMI is, for purposes of Sections 13(d) or 13(g) of the
Securities Exchange Act of 1934, the beneficial owner of any securities
covered by this statement.
/9/ See Item 4(a)(2).
/10/ See Item 4(a)(3).
/11/ See Item 4(a)(4).
/12/ See Item 4(a)(2).
<PAGE>
Schedule 13G Page 10 of 13
CUSIP No. 00437V104 Accredo Health, Inc.
- --------------------------------------------------------------------------------
(iv) Shared power to dispose or to direct the
disposition of: 0 /13/
------
(3) Stilwell Financial, Inc.
(i) Sole power to vote or to direct the
vote: 0
-----
(ii) Shared power to vote or to direct the
vote: 0 /14/
-----
(iii) Sole power to dispose or to direct the
disposition of: 0
-----
(iv) Shared power to dispose or to direct the
disposition of: 0 /15/
------
(4) Stilwell Management, Inc.
(i) Sole power to vote or to direct the
vote: 0
-----
(ii) Shared power to vote or to direct the
vote: 0 /16/
-----
(iii) Sole power to dispose or to direct the
disposition of: 0
-----
(iv) Shared power to dispose or to direct the
disposition of: 0 /17/
------
Item 5. Ownership of Five Percent or Less of a Class:
N/A
Item 6. Ownership of More than Five Percent on Behalf of Another
Person:
N/A
- ------------------------
/13/ See Item 4(a)(2).
/14/ See Item 4(a)(3).
/15/ See Item 4(a)(3).
/16/ See Item 4(a)(4).
/17/ See Item 4(a)(4).
<PAGE>
Schedule 13G Page 11 of 13
CUSIP No. 00437V104 Accredo Health, Inc.
- --------------------------------------------------------------------------------
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding
Company:
This statement has been filed jointly by KCSI, SFI, SMI, and
Berger LLC and information relating to Berger LLC has been
included herein.
Item 8. Identification and Classification of Members of the Group:
N/A
Item 9. Notice of Dissolution of Group:
N/A
Item 10. Certification:
N/A
<PAGE>
Schedule 13G Page 12 of 13
CUSIP No. 00437V104 Accredo Health, Inc.
- --------------------------------------------------------------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
BERGER LLC:
February 15, 2000
--------------------------------------------
Date
/s/ Brian S. Ferrie
--------------------------------------------
Signature
Brian S. Ferrie, Vice President - Compliance
--------------------------------------------
Name/Title
KANSAS CITY SOUTHERN INDUSTRIES, INC.
February 15, 2000
--------------------------------------------
Date
/s/ Joseph D. Monello
--------------------------------------------
Signature
Joseph D. Monello
Vice President and Chief Financial Officer
--------------------------------------------
Name/Title
<PAGE>
Schedule 13G Page 13 of 13
CUSIP No. 00437V104 Accredo Health, Inc.
- --------------------------------------------------------------------------------
STILWELL FINANCIAL, INC.
/s/ Joseph D. Monello
Date: February 15, 2000 --------------------------------------------
Signature
Joseph D. Monello,
Executive Vice President
--------------------------------------------
Name/Title
STILWELL MANAGEMENT, INC.
/s/ Janice M. Teague
Date: February 15, 2000 --------------------------------------------
Signature
Janice M. Teague,
Vice President - Administration
--------------------------------------------
Name/Title
<PAGE>
EXHIBIT INDEX
Exhibit Document Page No.
- ------- -------- --------
A Joint Filing Agreement A-1
<PAGE>
Exhibit A
to
SCHEDULE 13G
(AMENDMENT NO. 1)
JOINT FILING AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934,
the undersigned parties hereby agree that the preceding Schedule 13G,
Amendment No. 1, is being filed on behalf of each of them.
IN WITNESS WHEREOF, the parties hereto have duly executed this
agreement on this 15th day of February, 2000.
BERGER LLC:
/s/ Brian S. Ferrie
--------------------------------------------
Brian S. Ferrie
Vice President - Compliance
KANSAS CITY SOUTHERN INDUSTRIES, INC.
/s/ Joseph D. Monello
--------------------------------------------
Joseph D. Monello
Vice President and Chief Financial Officer
STILWELL FINANCIAL, INC.
/s/ Joseph D. Monello
--------------------------------------------
Joseph D. Monello
Executive Vice President
STILWELL MANAGEMENT, INC.
/s/ Janice M. Teague
--------------------------------------------
Janice M. Teague
Vice President - Administration
A-1
